Aprea Therapeutics, Inc. (APRE) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.93 | +17.9% |
| 2024 | $-2.35 | +40.5% |
| 2023 | $-3.95 | +94.2% |
| 2022 | $-67.99 | -94.9% |
| 2021 | $-34.88 | +31.1% |
| 2020 | $-50.61 | -983.7% |
| 2019 | $-4.67 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.93 | +17.9% |
| 2024 | $-2.35 | +40.5% |
| 2023 | $-3.95 | +94.2% |
| 2022 | $-67.99 | -94.9% |
| 2021 | $-34.88 | +31.1% |
| 2020 | $-50.61 | -983.7% |
| 2019 | $-4.67 | — |